PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.\', \'Department of Medicine, Division of Cardiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Internal Medicine III, Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University of Salzburg, Salzburg, Austria.\', \'Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria. m.lichtenauer@salk.at.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11239-020-02212-6
?:hasPublicationType
?:journal
  • Journal of thrombosis and thrombolysis
is ?:pmid of
?:pmid
?:pmid
  • 32632558
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.991
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all